GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Net Income (Continuing Operations)

Cessatech AS (XSAT:CESSA) Net Income (Continuing Operations) : kr-24.87 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cessatech AS's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was kr-2.71 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-24.87 Mil.

Cessatech AS Net Income (Continuing Operations) Historical Data

The historical data trend for Cessatech AS's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Net Income (Continuing Operations) Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
- -11.57 -14.66 -26.53

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.37 -5.30 -6.61 -10.25 -2.71

Cessatech AS Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cessatech AS  (XSAT:CESSA) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Cessatech AS Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS (XSAT:CESSA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Net Income (Continuing Operations)
Comparable Companies
OSTO:ACE OSTO:ZICC OSTO:SIMRIS B OSTO:NXTCL OSTO:LIPUM NGM:GTAB B OSTO:BIOVIC B OSTO:ALZ XSAT:DEX OSTO:XINT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
8GN:Germany
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Website
https://www.cessatech.com
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS (XSAT:CESSA) Headlines

No Headlines